MedTrace Logo

Hospital Airway Resuscitation Trial

NCT05520762 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1060

Last updated 2025-11-21

No results posted yet for this study

Summary

The Hospital Airway Resuscitation Trial (HART) is a cluster-randomized, pragmatic trial of advanced airway management with a strategy of first choice supraglottic airway vs. first choice endotracheal intubation during in-hospital cardiac arrest.

Conditions

Interventions

PROCEDURE

A strategy of first choice supraglottic airway

See description in Arms section

PROCEDURE

A strategy of first choice endotracheal intubation

See description in Arms section

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Ari Moskowitz, MD · Montefiore Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-10
Primary Completion
2027-01-31
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05520762 on ClinicalTrials.gov